美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

BRIACELL THERAPEUTICS CORP C/WTS (TO PUR COM) 15/01/2031

0.8850

-0.0350-3.80%

成交量：6,979

成交额：6,243

市值：- -

市盈率：- -

高：0.9500

开：0.9500

低：0.8700

收：0.9200

52周最高：1.40

52周最低：0.6100

股本：- -

流通股本：- -

量比：0.59

换手率：- -

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻

Briacell启动加拿大首个临床站点——Sunnybrook，用于转移性乳腺癌关键性III期试验

Briacell与富士胶片生物技术加州公司就Bria-IMT达成生产协议

Briacell公司达成生产协议，为三期临床及商业化量产铺路

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/BCTXL"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BCTXL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCTXL\",,,,,undefined,":{"symbol":"BCTXL","market":"US","secType":"STK","nameCN":"BRIACELL THERAPEUTICS CORP C/WTS (TO PUR COM) 15/01/2031","latestPrice":0.885,"timestamp":1789070400000,"preClose":0.92,"halted":0,"volume":6979,"delay":0,"changeRate":-0.038043478260869595,"floatShares":0,"shares":0,"eps":0,"marketStatus":"盘前交易","change":-0.035,"latestTime":"09-11 08:47:21 EDT","open":0.94999,"high":0.94999,"low":0.87,"amount":6243,"amplitude":0.086946,"askPrice":0.99,"askSize":495,"bidPrice":0.734,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789133400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.885,"volumeRatio":0.5874677955651197},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCTXL\",,,,,undefined,":{"symbol":"BCTXL","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5874677955651197,"shares":0,"dividePrice":0,"high":0.94999,"amplitude":0.086946,"preClose":0.92,"low":0.87,"week52Low":0.61,"pbRate":"--","week52High":1.4,"institutionHeld":0,"latestPrice":0.885,"committee":-0.663866,"eps":0,"divideRate":0,"volume":6979,"delay":0,"ttmEps":0,"open":0.94999,"prevYearClose":0.65,"prevWeekClose":0.9466,"prevMonthClose":0.925,"prevQuarterClose":0.89,"fiveDayClose":0.94,"twentyDayClose":0.85,"sixtyDayClose":0.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCTXL\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCTXL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCTXL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCTXL\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1197584324","title":"Briacell启动加拿大首个临床站点——Sunnybrook，用于转移性乳腺癌关键性III期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1197584324","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197584324?lang=zh_cn&edition=fundamental","pubTime":"2026-07-16 19:37","pubTimestamp":1784201833,"startTime":"0","endTime":"0","summary":"Briacell Therapeutics Corp. 已正式启动其在加拿大的首个临床研究中心——位于多伦多的Sunnybrook健康科学中心，以推进其针对转移性乳腺癌的关键性III期临床试验。这一进展标志着该公司核心候选疗法Bria-IMT™联合检查点抑制剂的研究进入了一个重要阶段，旨在评估其在难治性转移性乳腺癌患者中的安全性与有效性。Sunnybrook作为加拿大顶尖的癌症研究与治疗机构之一，其参与有望加速患者招募并增强试验数据的权威性。此次III期试验的成功与否，对Briacell的未来商业化前景及股价走势可能产生深远影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTXL","BCTXZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116025944","title":"Briacell与富士胶片生物技术加州公司就Bria-IMT达成生产协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1116025944","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116025944?lang=zh_cn&edition=fundamental","pubTime":"2026-07-15 19:34","pubTimestamp":1784115281,"startTime":"0","endTime":"0","summary":"Briacell Therapeutics Corp宣布，已与富士胶片生物技术加州公司就其实验性癌症免疫疗法Bria-IMT达成了生产安排。该协议旨在为Bria-IMT的临床开发和未来潜在的商业化提供支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTXL","BCTXZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107769441","title":"Briacell公司达成生产协议，为三期临床及商业化量产铺路","url":"https://stock-news.laohu8.com/highlight/detail?id=1107769441","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107769441?lang=zh_cn&edition=fundamental","pubTime":"2026-07-15 19:33","pubTimestamp":1784115213,"startTime":"0","endTime":"0","summary":"Briacell Therapeutics Corp宣布达成一项关键的生产安排。此举旨在确保其候选疗法在关键三期临床研究阶段拥有充足的生产能力，并为未来潜在的大规模商业化生产奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTXZ","BCTXL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BCTXL\",params:#limit:6,delay:false,,,undefined,":[]}}